Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Nicol

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
BJU International|April 12, 2002
Renal cell carcinoma may adapt to and overcome anti-angiogenic intervention with thalidomideM L Douglas, J L Reid, S I Hii, et al.
The Journal of Urology|June 18, 2004
Repeat urethrotomy and dilation for the treatment of urethral stricture are neither clinically effective nor cost-effectiveT J Greenwell, C Castle, D E Andrich, et al.
British Journal of Cancer|April 7, 1998
Captopril inhibits tumour growth in a xenograft model of human renal cell carcinomaS I Hii, D L Nicol, D C Gotley, et al.
Genomics|October 13, 2001
TTYH2, a human homologue of the Drosophila melanogaster gene tweety, is located on 17q24 and upregulated in renal cell carcinomaF K Rae, J D Hooper, H J Eyre, et al.
The Medical Journal of Australia|June 19, 1998
Health-related quality of life in Australian men remaining disease-free after radical prostatectomyP S Heathcote, P N Mactaggart, R J Boston, et al.
Transplantation|February 7, 2001
A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patientsD W Johnson, K Herzig, D Purdie, et al.
British Journal of Cancer|August 17, 2001
An orthotopic xenograft model of human nonseminomatous germ cell tumourM L Douglas, K J Boucaut, T M Antalis, et al.
Transplantation|April 1, 1993
Reduction by combination prophylactic therapy with CMV hyperimmune globulin and acyclovir of the risk of primary CMV disease in renal transplant recipientsD L Nicol, A S MacDonald, P Belitsky, et al.
Endocrine-Related Cancer|September 21, 2005
Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cellsT L Veveris-Lowe, M G Lawrence, R L Collard, et al.
The Journal of Urology|July 13, 2004
Re: The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancerR A Gardiner, D L Nicol, H J Green, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
BJU International|April 12, 2002
Renal cell carcinoma may adapt to and overcome anti-angiogenic intervention with thalidomideM L Douglas, J L Reid, S I Hii, et al.
The Journal of Urology|June 18, 2004
Repeat urethrotomy and dilation for the treatment of urethral stricture are neither clinically effective nor cost-effectiveT J Greenwell, C Castle, D E Andrich, et al.
British Journal of Cancer|April 7, 1998
Captopril inhibits tumour growth in a xenograft model of human renal cell carcinomaS I Hii, D L Nicol, D C Gotley, et al.
Genomics|October 13, 2001
TTYH2, a human homologue of the Drosophila melanogaster gene tweety, is located on 17q24 and upregulated in renal cell carcinomaF K Rae, J D Hooper, H J Eyre, et al.
The Medical Journal of Australia|June 19, 1998
Health-related quality of life in Australian men remaining disease-free after radical prostatectomyP S Heathcote, P N Mactaggart, R J Boston, et al.
Transplantation|February 7, 2001
A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patientsD W Johnson, K Herzig, D Purdie, et al.
British Journal of Cancer|August 17, 2001
An orthotopic xenograft model of human nonseminomatous germ cell tumourM L Douglas, K J Boucaut, T M Antalis, et al.
Transplantation|April 1, 1993
Reduction by combination prophylactic therapy with CMV hyperimmune globulin and acyclovir of the risk of primary CMV disease in renal transplant recipientsD L Nicol, A S MacDonald, P Belitsky, et al.
Endocrine-Related Cancer|September 21, 2005
Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cellsT L Veveris-Lowe, M G Lawrence, R L Collard, et al.
The Journal of Urology|July 13, 2004
Re: The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancerR A Gardiner, D L Nicol, H J Green, et al.
Pageof 3